Masayoshi Yamaguchi

Masayoshi Yamaguchi (山口 正義, Yamaguchi Masayoshi) (born 1947 in Atami, Japan) is a Japanese scientist and researcher in the biomedical fields related to biochemistry, endocrinology, metabolism, nutrition, pharmacology and toxicology.

Career

He graduated with a bachelor's degree from Shizuoka College of Pharmacy in 1971,[1] and obtained his Ph.D in Pharmaceutical Sciences in 1976 in Japan. He was engaged as a research associate and assistant professor in Shizuoka College from 1973 to 1987, as assistant professor in the University of Shizuoka School of Pharmaceutical Sciences from 1987 to 1991, as associate professor in the University of Shizuoka's Graduate School of Nutritional Sciences from 1991 to 1993, and a professor at the University of Shizuoka Graduate School of Nutritional Sciences from 1993 to 2007. In 2007, Yamaguchi was invited to be visiting professor to the Emory University School of Medicine in Atlanta, Georgia, at the Department of Medicine, Division of Endocrinology and Metabolism and Lipids, where he worked until 2011. He received permanent residence in the United States in 2011. He collaborated as a visiting professor at the Baylor College of Medicine, Department of Medicine from 2012 to 2013, in Houston. Yamaguchi was then appointed as adjunct professor at Emory in the Department of Hematology and Medical Oncology from 2013 to 2016.

Research

Yamaguchi's research was focused on the fields of bone and calcium endocrinology, metabolism, cell calcium signaling, gene regulation, nutritional osteoporosis prevention, carcinogenesis, and cancer therapy. Yamaguchi discovered the novel protein and genes which were named as Regucalcin[2] and RGPR-p117.[3][4] Yamaguchi had over 20 patents, and has published over 550 papers and review articles, four books, and edited 10 further books. He served as an editorial board member on 80 international journals. Yamaguchi was appointed to the Japanese Society for Biochemistry and Endocrine Society for Japan. He was a member of the New York Academy of Sciences from 1996 to 2012, the American Society for Bone and Mineral Research from 1999 to 2016, and been a member of the American Society for Biochemistry and Molecular Biology since 2005.

References
  1. "j-global entry" (in Japanese). JST. Retrieved 31 July 2011.
  2. Yamaguchi M (2017): Book, Title: "The Role of Regucalcin in Cell Homeostasis and Disorder". Nova Science Publishers, Inc., New York, page 1-288.
  3. Yamaguchi M (2009): "Novel protein RGPR-p117: its role as the regucalcin gene transcription factor". Mol Cell Biochem 327:53-63.
  4. Yamasguchi M, Murata T (2017): "Involvement of regucalcin gene promoter region-related protein-117, a transcription factor, in human obesity (Review)". Biomedical Reports 6:374–378.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.